Soleno Therapeutics Inc (SLNO) Revenue (2015 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Revenue of $94.6 million for Q1 2026, up 3.13% sequentially from $91.7 million in Q4 2025.
Soleno Therapeutics Inc (SLNO) Revenue (2015 - 2026) Analysis & Trends
Soleno Therapeutics has disclosed Revenue across 5 years of filings, most recently posting $94.6 million for Q1 2026.
- In Q1 2026, Revenue changed N/A year-over-year to $94.6 million; the TTM figure through Mar 2026 stood at $285.0 million (changed N/A YoY), while the FY2025 annual figure was $190.4 million, changed N/A from the prior year.
- Revenue climbed to $94.6 million in Q1 2026, from $91.7 million in the prior quarter.
- Over the last five years, Revenue for SLNO reached as high as $94.6 million in Q1 2026 and fell as low as $32.7 million in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.60 Mn |
| Dec 31, 2025 | 91.73 Mn |
| Sep 30, 2025 | 66.02 Mn |
| Jun 30, 2025 | 32.66 Mn |
| Jun 30, 2017 | 1,000.00 |
| Mar 31, 2017 | 265,000.00 |
| Dec 31, 2016 | 1.45 Mn |
| Sep 30, 2016 | 329,000.00 |
| Jun 30, 2016 | 2,000.00 |
| Mar 31, 2016 | 447,000.00 |
| Dec 31, 2015 | 73,917.00 |
| Sep 30, 2015 | 27,000.00 |
| Jun 30, 2015 | 97,000.00 |
| Mar 31, 2015 | 22,000.00 |